Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Open in API
Filings indexed 477 across all filing types
Latest filing 2014-07-07 Legal Proceedings Report
Country CH Switzerland
Listing SW ROSE

About Zur Rose Group AG

https://www.zurrosegroup.com/websites/z…

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
Zur Rose AG: Bundesgericht zur Zusammenarbeit zwischen Arzten mit Zur Rose im Kanton Zurich: Entschadigungen fur elektronisch rezeptierende Arzte in Zurich eingeschrankt; Entscheid betrifft 35 Arzte
Legal Proceedings Report Classification · 99% confidence The document is a short press release dated July 7, 2014, from Zur Rose AG concerning a Federal Court (Bundesgericht) ruling regarding compensation for doctors related to electronic prescriptions and medication dispensing. It details a legal matter affecting the company's operations and mentions the impact on 35 doctors. Since it is an update on a significant lawsuit/regulatory action, it fits the description of a Legal Proceedings Report (LTR). It is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it specifically addresses a legal outcome.
2014-07-07 German
Annual Report 2013
Annual Report Classification · 100% confidence The document is titled 'Geschäftsbericht 2013' (Annual Report 2013) for the Zur Rose Group. It contains a comprehensive overview of the company, including a letter to shareholders, financial highlights (Kennzahlen), detailed business development reports for various segments, corporate governance information, and a financial report section. It is a full annual report covering the fiscal year 2013, not an announcement or a summary. FY 2013
2014-04-11 English
Zur Rose AG: Exercice 2013 - acceleration prononcee de la croissance apres l'integration de DocMorris, resultat affaibli par des effets ponctuels
Earnings Release Classification · 100% confidence The document is a press release dated April 10, 2014, detailing the financial results for the 'Exercice 2013' (Fiscal Year 2013) of Zur Rose AG. It contains key financial figures (Revenue, EBITDA, EBIT), discusses operational performance, integration of DocMorris, and provides outlook for 2014. This structure—a comprehensive summary of annual performance, including a detailed financial table and management commentary—is characteristic of an Earnings Release (ER) or the summary section preceding a full Annual Report (10-K). However, the text explicitly mentions that the 'rapport de gestion 2013' (2013 management report) can be downloaded, suggesting this document is the initial announcement of the results, not the full statutory report itself. Given the detailed financial summary and the context of annual results, 'ER' (Earnings Release) is the most appropriate classification, as it announces the period's results, even though it is more detailed than a typical quarterly ER. It is not a 10-K because it points to the full management report elsewhere, and it is not an RPA because it contains the core results, not just an announcement of publication. FY 2013
2014-04-10 French
Zur Rose AG: Geschaftsjahr 2013 - markanter Wachstumsschub nach DocMorris-Integration; Einmaleffekte belasten Ergebnis
Earnings Release Classification · 100% confidence The document is a press release titled "Zur Rose AG: Geschäftsjahr 2013 – markanter Wachstumsschub nach DocMorris-Integration; Einmaleffekte belasten Ergebnis" (Zur Rose AG: Fiscal Year 2013 - Significant Growth Boost after DocMorris Integration; One-off Effects Burden Earnings). It details the company's financial performance for the fiscal year 2013, including revenue, EBITDA, EBIT, and net income, and provides an outlook for 2014. This content structure—summarizing annual results, key performance indicators in a table, and discussing business segments for a full year—is characteristic of an Earnings Release (ER) or potentially an Interim/Quarterly Report (IR) if it were for a shorter period. Since it explicitly covers the 'Geschäftsjahr 2013' (Fiscal Year 2013) and presents comprehensive annual figures, it functions as the initial announcement of the full-year results, making 'ER' (Earnings Release) the most appropriate classification, even though it contains more detail than a typical brief ER, as it is presented as a news announcement rather than the full 10-K filing itself. The document length (9319 chars) is substantial but still fits the format of a detailed earnings press release announcing the annual figures. FY 2013
2014-04-10 German
Geschäftsbericht 2013 Geschäftsbericht 2013
Annual Report Classification · 100% confidence The document is titled 'Geschäftsbericht 2013' (Annual Report 2013) for the Zur Rose Group. It contains a comprehensive overview of the company, including a letter to shareholders, financial highlights (Kennzahlen), detailed business development reports for various segments, corporate governance information, and a financial report section. It is a full annual report covering the fiscal year 2013, not an announcement or a summary. FY 2013
2014-04-10 German
Zur Rose AG: Nouvelle strategie concernant les sites: fermeture de la plate-forme logistique de Ceska Lipa le 31 mars 2014
Regulatory Filings Classification · 100% confidence The document is explicitly labeled as an "Ad-hoc" release and a "Communiqué de presse" (Press Release) published under Article 53 of the relevant regulations (RC). It announces a strategic decision regarding site restructuring and the closure of a logistics platform, effective on a future date (March 31, 2014). This type of immediate, material, non-periodic corporate action announcement, which is not a standard financial report (like 10-K or IR) or a specific insider/dividend/share change filing, fits best under the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS). Although it is a strategic announcement, it is not specifically covered by MANG (Board/Management change), TAR (M&A), or CAP (Financing). Given the context of an immediate, material, non-standard disclosure, RNS is the most appropriate fallback.
2013-12-27 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.